$4.8M in Congress trades disclosed this week

Senator exits Goldman Sachs position worth up to $5M. Top strategy up 4.92%. Full breakdown inside.

Author

David Love
February 27, 2026

THE QUIVER QUANT
EXECUTIVE SUMMARY

During Tuesday's State of the Union, President Trump urged Congress to "pass the Stop Insider Trading Act without delay." The bill would ban members, their spouses, and dependents from buying individual stocks. The moment drew a rare bipartisan standing ovation, though the bill still faces an uncertain path forward. We'll be tracking every move on Quiver.

Meanwhile, Senator David McCormick disclosed a full sale of Goldman Sachs stock worth up to $5 million. McCormick is the former CEO of Bridgewater Associates, and his wife Dina Powell McCormick is a Goldman Sachs partner. Worth watching closely.

On the strategy side, Cleo Fields is the hottest strategy on Quiver this week at +4.92%, and Aaron Bean leads the Congress portfolio leaderboard at +26.13%.

On the insider trading front, MSCI saw a $2M director purchase, the largest unscheduled buy we tracked this week. Conduent's CEO bought $313K of stock after a 30% drawdown, and an Accuray director made a first-ever $100K purchase on a stock down 60% in six months. More details in the insider section below.

Below: CNBC pick tracker, Quiver Strategies performance, Congress portfolio leaderboard, insider trading, and the editorial deep dive.

BUILDING QUIVER FOR YOU
Got 90 seconds? Tell us what features you want, report a bug, or let us know what is working. Every response gets read. Share your feedback here →

STRATEGY PERFORMANCE

Track every trade in real time with Quiver Premium

THE EDITORIAL QUANT
The $19,680 Trade That Ended a Career

On January 26, the SEC settled charges against Brian Suthoff, a Massachusetts resident who sold his entire position in Sage Therapeutics after learning from a company insider that the FDA had struck major depressive disorder from the proposed label of Sage's flagship drug, zuranolone. Suthoff had held those shares for more than two years. He dumped them right before Sage announced the FDA's decision on August 4, 2023. The stock fell 53%. His avoided losses: $19,680.

The Suthoff case is the smallest dollar amount the SEC has pursued in a stand-alone insider trading action in recent memory. It sends a clear message. See the full breakdown →

Want more stories like this in your inbox every week?

POLITICS
Congress Activity

QUIVER DATA
CNBC Tracker

CONGRESS TRADING ALERT

INSIDER TRADING
Significant Insider Purchases

QUIVER NEWS
What we’re watching:
→ Nvidia Crushes Q1 Guidance as Big Tech’s AI Spending Hits $630B

Nvidia solidified its standing as the primary beneficiary of the global AI infrastructure race, issuing a: Read analysis →

→ Supreme Court Strikes Down Trump’s Tariffs

The U.S. Supreme Court struck down President Donald Trump’s sweeping global tariffs, ruling on Feb. 20, 2026 that the administration exceeded: Read analysis →

→ Lockheed and Boeing Audited by Defense Department Over Anthropic

The Pentagon is ramping up pressure on defense contractors to disclose their dependence on Anthropic, signaling a potential rupture: Read analysis →

SOCIAL MEDIA ROUNDUP
WHAT QUIVER’S POSTING

@quiverquant

SOMETHING’S COOKIN’! 🧑‍🍳 #quiverquant #geopolitics #military #investing #fyp